Medicine Man Technologies Inc OTCMKTS: MDCL is a fully integrated operator in the cannabis industry, offering consulting, cultivation supplies and equipment, retail pharma-grade products, and turnkey solutions for cannabis producers, processors, and retailers for nearly a decade. Medicine Man Technologies is leveraging its expertise and intellectual property to vertically integrate retail, cultivation, formulation and distribution operations. The Company’s client portfolio includes active and past clients in 18 states and seven countries.
On April, 2019 Medicine Man Technologies Inc announced that one of its investors, Tigran Muradyan has joined the management team as Director of Products. In his position at Medicine Man Technologies, Mr. Muradyan will work closely with the executive management team in the development and execution of an array of products and services offered by Medicine Man Technologies, thus furthering the growth of the Company’s revenue.
Mr. Muradyan facilitated an investment of approximately $1 million in Medicine Man Technologies through the purchase of 600,000 common stock shares from Joshua Haupt, Medicine Man Technologies’ Chief Revenue Officer. He personally purchased 400,000 of those shares.
Mr. Muradyan brings a wealth of sales experience with him to Medicine Man Technologies. He is an experienced business development officer with extensive expertise in the financial services industry and knowledge within securities, investment advisory, management, and securities regulation. Most recently he served as an external financial wholesaler, raising $530 million throughout 2017 and 2018.
“During the span of his career, Tigran has distinguished himself as a top industry advisor, critical thinker, and top sales executive, demonstrating his ability to lead conversations about industry trends, challenges, and opportunities,” said Joe Puglise, Chief Operating Officer of Medicine Man Technologies. “His deep experience will be instrumental in the development of our next generation of products and services as a vertically integrated cannabis brand and operator.”
Mr. Muradyan started his career in banking and later moved to investments, obtaining his series 7, 63, and 65 licenses to become a stockbroker. He recently served as Business Development Officer at AssetMark, an investment adviser and a leading independent provider of innovative investment and consulting solutions serving financial advisors. Prior to that he was an External Senior Regional Business Consultant at Curian Capital, a registered investment advisor providing wealth management platforms to its financial professionals.
The company on April 9th, 2019 announced that it will be presenting at the 3rd Annual Benzinga Cannabis Capital Conference, to be held April 17-18, 2019 at the Fairmont Royal York in Toronto, Canada.
Andy Williams, Co-Founder and CEO of Medicine Man Technologies, will deliver a corporate presentation and discuss recent highlights of the Company on Thursday, April 18 at 11:20 a.m. ET in the British Columbia Room.
“This is one of the premiere conferences within the emerging cannabis space for small-cap companies,” said Mr. Williams. “We are excited to be participating and presenting the latest highlights from our Company, which include our year-over-year profitable growth and pending acquisitions of MedPharm Holdings, LLC and Medicine Man Denver.”
Medicine Man Technologies is a profitable first mover in the cannabis industry, with a revenue run rate expected to exceed $40m upon completion of its pending acquisitions. The Medicine Man Technologies brand has earned a best-in-class reputation for its cultivation and extraction expertise, working with over 100 clients in 18 states and seven countries.
About the Third Annual Benzinga Cannabis Capital Conference
The 3rd Annual Benzinga Cannabis Capital Conference is scheduled to be held April 17-18, 2019 in Toronto, Ontario, Canada. The conference is the premier gathering of cannabis entrepreneurs and investors in North America and offers high-level access and seamless interaction between the two. The two days feature discussions of post-legalization Canada, market volatility and emerging markets, as well as networking with fundamental players and workshops with influencers, policymakers and trailblazers.